Ingrid Stacey (née Boehm)
Ingrid Stacey (née Boehm)
Cancer Institute of New South Wales
Verified email at
Cited by
Cited by
Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential
MA Bogoyevitch, I Boehm, A Oakley, AJ Ketterman, RK Barr
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1697 (1-2), 89-101, 2004
Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104
J Benito, Y Shi, B Szymanska, H Carol, I Boehm, H Lu, S Konoplev, ...
PloS one 6 (8), e23108, 2011
Rapid Detection of vanA and vanB Genes Directly from Clinical Specimens and Enrichment Broths by Real-Time Multiplex PCR Assay
S Palladino, ID Kay, JP Flexman, I Boehm, AMG Costa, EJ Lambert, ...
Journal of Clinical Microbiology 41 (6), 2483-2486, 2003
Association between tobacco plain packaging and Quitline calls: a population‐based, interrupted time‐series analysis
JM Young, I Stacey, TA Dobbins, S Dunlop, AL Dessaix, DC Currow
Medical Journal of Australia 200 (1), 29-32, 2014
Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer
H Carol, I Boehm, CP Reynolds, MH Kang, JM Maris, CL Morton, ...
Cancer chemotherapy and pharmacology 68 (5), 1291-1304, 2011
The anti-CD19 antibody–drug conjugate SAR3419 prevents hematolymphoid relapse postinduction therapy in preclinical models of pediatric acute lymphoblastic leukemia
H Carol, B Szymanska, K Evans, I Boehm, PJ Houghton, MA Smith, ...
Clinical Cancer Research 19 (7), 1795-1805, 2013
The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNK
RK Barr, I Boehm, PV Attwood, PM Watt, MA Bogoyevitch
Journal of Biological Chemistry 279 (35), 36327-36338, 2004
Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts
S Suryani, H Carol, TN Chonghaile, V Frismantas, C Sarmah, L High, ...
Clinical Cancer Research 20 (17), 4520-4531, 2014
Pharmacokinetic modeling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenografts
B Szymanska, U Wilczynska-Kalak, MH Kang, NLM Liem, H Carol, ...
PloS one 7 (3), e33894, 2012
Unconditional and conditional incentives differentially improved general practitioners' participation in an online survey: randomized controlled trial
JM Young, A O'Halloran, C McAulay, M Pirotta, K Forsdike, I Stacey, ...
Journal of clinical epidemiology 68 (6), 693-697, 2015
High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus
FF Yuan, I Boehm, PKS Chan, K Marks, JW Tang, DSC Hui, JJY Sung, ...
Clinical and Vaccine Immunology 14 (12), 1644-1645, 2007
Knowledge of the signs and symptoms and risk factors of lung cancer in Australia: mixed methods study
M Crane, N Scott, BJ O’Hara, S Aranda, M Lafontaine, I Stacey, M Varlow, ...
BMC public health 16 (1), 1-12, 2016
Efficacy of CPX‐351,(cytarabine: daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program
H Carol, MMY Fan, TO Harasym, I Boehm, LD Mayer, P Houghton, ...
Pediatric blood & cancer 62 (1), 65-71, 2015
Heterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culture
JS Sullivan, PW Selleck, T Downton, I Boehm, AM Axell, Y Ayob, ...
Journal of molecular and genetic medicine: an international journal of …, 2009
Contemporary incidence and prevalence of Rheumatic Fever and Rheumatic Heart Disease in Australia using linked data: the case for policy change
JM Katzenellenbogen, D Bond‐Smith, RJ Seth, K Dempsey, J Cannon, ...
Journal of the American Heart Association 9 (19), e016851, 2020
Self-reported participation and beliefs about bowel cancer screening in New South Wales, Australia
M Varlow, I Stacey, S Dunlop, J Young, J Kite, A Dessaix, C McAulay
Health Promotion Journal of Australia 25 (2), 97-103, 2014
Cross-reactive anti-avian H5N1 influenza neutralizing antibodies in a normal ‘exposure-naive’Australian blood donor population
GW Lynch, PW Selleck, AM Axell, T Downton, NM Kapitza, I Boehm, ...
The Open Immunology Journal 1 (1), 2008
Development and Use of a Peptide Inhibitor of the c-Jun N-terminal kinase (JNK) Subfamily of Mitogen-Activated Protein Kinases
MA Bogoyevitch, RK Barr, RM Hopkins, PM Watt, I Boehm, A Chan, ...
Cellular and Molecular Biology Letters 8 (2A), 550-551, 2003
Abstract C107: The anti-CD19 antibody-drug conjugate SAR3419 prevents hematolymphoid relapse post induction therapy in preclinical models of pediatric acute lymphoblastic leukemia.
RB Lock, H Carol, B Szymanska, I Boehm, K Evans, PJ Houghton, ...
Molecular Cancer Therapeutics 10 (11 Supplement), C107-C107, 2011
CD14-159CC, another risk genotype for severe SARS-CoV infection
FF Yuan, I Boehm, PKS Chan, K Marks, JW Tang, DSC Hui, JJY Sung, ...
Clinical and Vaccine Immunology, 2007
The system can't perform the operation now. Try again later.
Articles 1–20